133 related articles for article (PubMed ID: 28990250)
21. Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis.
Huang J; Zeng T; Zhang X; Tian Y; Wu Y; Yu J; Pei Z; Liu Y; Hu T; Tan L
Br J Biomed Sci; 2020 Jan; 77(1):19-23. PubMed ID: 31433746
[No Abstract] [Full Text] [Related]
22. Association among anti-citrullinated protein antibody status, erosive disease and healthcare resource utilization in patients with rheumatoid arthritis.
Harrold LR; Shan Y; Connolly SE; Alemao E; Rebello S; Guo L; Kremer JM
Curr Med Res Opin; 2020 Feb; 36(2):337-342. PubMed ID: 31612736
[No Abstract] [Full Text] [Related]
23. Synovium CD20 expression is a potential new predictor of bone erosion progression in very-early arthritis treated by sequential DMARDs monotherapy -- a pilot study from the VErA cohort.
Lanfant-Weybel K; Michot C; Daveau R; Milliez PY; Auquit-Auckbur I; Fardellone P; Brazier M; Mejjad O; Daragon A; Krzanowska K; Jouen F; Tron F; Le Loarer F; Le Loët X; Vittecoq O
Joint Bone Spine; 2012 Dec; 79(6):574-80. PubMed ID: 22459417
[TBL] [Abstract][Full Text] [Related]
24. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
[TBL] [Abstract][Full Text] [Related]
25. Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry.
Huang S; He X; Doyle TJ; Zaccardelli A; Marshall AA; Friedlander HM; Blaustein RB; Smith EA; Cui J; Iannaccone CK; Mahmoud TG; Weinblatt ME; Dellaripa PF; Shadick NA; Sparks JA
Clin Rheumatol; 2019 Dec; 38(12):3401-3412. PubMed ID: 31410660
[TBL] [Abstract][Full Text] [Related]
26. Comparative evaluation of treatment patterns and healthcare utilization of newly-diagnosed rheumatoid arthritis patients by anti-cyclic citrullinated peptide antibody status.
Lamerato L; Price K; Szymialis R; Eaddy M; Ogbonnaya A; Shih HC; Ahmad H
J Med Econ; 2018 Mar; 21(3):231-240. PubMed ID: 29027497
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients.
Meyer PWA; Ally MTM; Hodkinson B; Anderson R; Tikly M
Rheumatol Int; 2018 Jun; 38(6):993-1001. PubMed ID: 29713794
[TBL] [Abstract][Full Text] [Related]
28. Rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibodies with hepatitis B and hepatitis C infection: Review.
Zengin O; Yıldız H; Demir ZH; Dağ MS; Aydınlı M; Onat AM; Kısacık B
Adv Clin Exp Med; 2017 Sep; 26(6):987-990. PubMed ID: 29068601
[TBL] [Abstract][Full Text] [Related]
29. Galectin 3 and its binding protein in rheumatoid arthritis.
Ohshima S; Kuchen S; Seemayer CA; Kyburz D; Hirt A; Klinzing S; Michel BA; Gay RE; Liu FT; Gay S; Neidhart M
Arthritis Rheum; 2003 Oct; 48(10):2788-95. PubMed ID: 14558084
[TBL] [Abstract][Full Text] [Related]
30. Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study.
Berendsen MLT; van Maaren MC; Arts EEA; den Broeder AA; Popa CD; Fransen J
J Rheumatol; 2017 Sep; 44(9):1325-1330. PubMed ID: 28668802
[TBL] [Abstract][Full Text] [Related]
31. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis.
Lingampalli N; Sokolove J; Lahey LJ; Edison JD; Gilliland WR; Holers VM; Deane KD; Robinson WH
Clin Immunol; 2018 Oct; 195():119-126. PubMed ID: 29842946
[TBL] [Abstract][Full Text] [Related]
32. Computerized measurement of magnetic resonance imaging erosion volumes in patients with rheumatoid arthritis: a comparison with existing magnetic resonance imaging scoring systems and standard clinical outcome measures.
Bird P; Lassere M; Shnier R; Edmonds J
Arthritis Rheum; 2003 Mar; 48(3):614-24. PubMed ID: 12632412
[TBL] [Abstract][Full Text] [Related]
33. Association of High Anti-Cyclic Citrullinated Peptide Seropositivity and Lean Mass Index With Low Bone Mineral Density in Rheumatoid Arthritis.
Wysham KD; Shoback DM; Imboden JB; Katz PP
Arthritis Care Res (Hoboken); 2018 Jul; 70(7):961-969. PubMed ID: 29106028
[TBL] [Abstract][Full Text] [Related]
34. Galectin-3: A key player in arthritis.
Hu Y; Yéléhé-Okouma M; Ea HK; Jouzeau JY; Reboul P
Joint Bone Spine; 2017 Jan; 84(1):15-20. PubMed ID: 27238188
[TBL] [Abstract][Full Text] [Related]
35. Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX®: a registry study of RA with osteoporosis/fracture.
Cheng TT; Yu SF; Su FM; Chen YC; Su BY; Chiu WC; Hsu CY; Chen JF; Ko CH; Lai HM
Arthritis Res Ther; 2018 Jan; 20(1):16. PubMed ID: 29382355
[TBL] [Abstract][Full Text] [Related]
36. Association of anti-cyclic citrullinated protein antibodies, erosions, and rheumatoid factor with disease activity and work productivity: A patient registry study.
Alemao E; Guo Z; Frits ML; Iannaccone CK; Shadick NA; Weinblatt ME
Semin Arthritis Rheum; 2018 Apr; 47(5):630-638. PubMed ID: 29241640
[TBL] [Abstract][Full Text] [Related]
37. [Correlation between synovial TRAF6 expression and serum bone metabolism markers in rheumatoid arthritis].
Zhu L; Ouyang X; Zheng D; Ma J; Chen L; Wei X; Mo Y; Dai L
Zhonghua Yi Xue Za Zhi; 2014 Jun; 94(21):1643-6. PubMed ID: 25152288
[TBL] [Abstract][Full Text] [Related]
38. Anti-cyclic citrullinated peptide antibodies are highly associated with severe bone lesions in rheumatoid arthritis anti-CCP and bone damage in RA.
Bongi SM; Manetti R; Melchiorre D; Turchini S; Boccaccini P; Vanni L; Maggi E
Autoimmunity; 2004; 37(6-7):495-501. PubMed ID: 15621577
[TBL] [Abstract][Full Text] [Related]
39. Clinical Significance of Red Blood Cell Distribution Width and Inflammatory Factors for the Disease Activity in Rheumatoid Arthritis.
Yunchun L; Yue W; Jun FZ; Qizhu S; Liumei D
Clin Lab; 2016 Dec; 62(12):2327-2331. PubMed ID: 28164544
[TBL] [Abstract][Full Text] [Related]
40. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Mathsson L; Mullazehi M; Wick MC; Sjöberg O; van Vollenhoven R; Klareskog L; Rönnelid J
Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
